Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/30/24 19:18 | 8/29/24 | CGON | Health | BioPrd | Biological Products, (No Diag | Song Hong Fang | K3 | D | S | -23,000 | 35.36 | 0 | -650 | -12 | 4,905 | I | |||||||||||||||
4/9/24 19:08 | 1/29/24 | CGON | Health | BioPrd | Biological Products, (No Diag | Decheng Capital Global Life Sciences Fund Iv, L.P. | CA | T | P.a | 7,600 | 19.00 | 0 | 400 | 9 | 4,959 | D | |||||||||||||||
1/31/24 16:30 | 1/29/24 | CGON | Health | BioPrd | Biological Products, (No Diag | Kasturi Vijay | CA | O | Chief Me | P | 25 | 19.00 | 0 | 1 | New | 1 | D | ||||||||||||||
1/31/24 16:30 | 1/29/24 | CGON | Health | BioPrd | Biological Products, (No Diag | Roche Corleen M. | CA | O | CFO,Secr | P | 38 | 19.00 | 0 | 2 | New | 2 | D | ||||||||||||||
1/31/24 16:30 | 1/29/24 | CGON | Health | BioPrd | Biological Products, (No Diag | Song Hong Fang | K3 | D | P.d | 5,000 | 19.00 | 0 | 263 | 5 | 5,555 | M | |||||||||||||||
1/31/24 16:17 | 1/29/24 | CGON | Health | BioPrd | Biological Products, (No Diag | Decheng Capital Global Life Sciences Fund Iv, L.P. | E9 | T | P.d | 7,600 | 19.00 | 0 | 400 | 9 | 4,959 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |